Performance Food Group insider sale notice: 6,334 shares via Morgan Stanley

Rhea-AI Filing Summary

Performance Food Group Company (PFGC) Form 144 shows a proposed sale of 6,334 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $642,267.60. The securities were acquired and are to be sold on 09/02/2025 following an exercise of stock options and paid in cash. The filing lists total shares outstanding as 156,519,106. The notice also discloses multiple prior 10b5-1 sales by the same seller (Brent King) on 07/11/2025, 07/17/2025, 08/20/2025, and 08/25/2025, with gross proceeds shown for each sale. The filer certifies no undisclosed material adverse information as part of the Form 144 signature attestation.

Positive

• Clear disclosure of the acquisition method (exercise of stock options) and cash payment on 09/02/2025
• Broker and market identified: Morgan Stanley Smith Barney LLC executing on the NYSE
• Prior 10b5-1 sales are listed with dates and gross proceeds, enhancing transparency

Negative

• Issuer contact details in the issuer information table are not populated in the provided content
• Multiple recent insider sales are shown (07/11/2025 through 08/25/2025), which may merit investor attention despite being routine

Insights

Securities Analyst

TL;DR: Routine insider exercise and planned sale; amount small relative to company shares outstanding.

The filing documents an insider exercise of options and a proposed sale of 6,334 shares valued at $642,267.60 executed through Morgan Stanley Smith Barney on 09/02/2025. Compared with the stated 156,519,106 shares outstanding, the proposed sale is immaterial on a percentage basis. Multiple recent 10b5-1 sales by the same individual are disclosed with aggregate gross proceeds across four transactions shown in the filing. This pattern is consistent with prearranged trading plans rather than an ad hoc market exit.

Compliance / Risk Analyst

TL;DR: Filing appears compliant with Rule 144 and includes required attestation; documents recent 10b5-1 activity.

The Form 144 includes the required broker, share counts, acquisition method (exercise of options), payment method (cash), and the attestation that no undisclosed material adverse information is known. It also lists prior 10b5-1 sales with dates and gross proceeds, aiding transparency. The filing lacks certain issuer contact details in the table, but it contains the essential transactional disclosures required for public notice of intended insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6334	642267.60	156519106	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Exercise of Stock Options	Issuer			6334	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRENT KING 12500 West Creek Parkway Richmond VA 23238	Common	08/25/2025	1320	134185.00
10b5-1 Sales for BRENT KING 12500 West Creek Parkway Richmond VA 23238	Common	08/20/2025	9136	918316.00
10b5-1 Sales for BRENT KING 12500 West Creek Parkway Richmond VA 23238	Common	07/17/2025	6335	633500.00
10b5-1 Sales for BRENT KING 12500 West Creek Parkway Richmond VA 23238	Common	07/11/2025	7865	747175.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PFGC Form 144 filed for 09/02/2025 disclose?

It discloses a proposed sale of 6,334 common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $642,267.60, acquired by exercise of stock options and paid in cash on 09/02/2025.

Who executed the prior sales listed in the filing for PFGC?

The filing lists 10b5-1 sales for Brent King on 07/11/2025 (7,865 shares), 07/17/2025 (6,335 shares), 08/20/2025 (9,136 shares), and 08/25/2025 (1,320 shares) with gross proceeds shown for each sale.

How large is the proposed sale relative to PFGC shares outstanding?

The proposed sale of 6,334 shares is against 156,519,106 shares outstanding as listed, which is immaterial on a percentage basis.

What acquisition method is reported for the securities to be sold?

The securities were acquired on 09/02/2025 by exercise of stock options from the issuer, and payment was in cash.

Does the filer assert knowledge of undisclosed material information?

Yes. By signing the Form 144, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.